Page last updated: 2024-10-29

iohexol and Biliary Tract Cancer

iohexol has been researched along with Biliary Tract Cancer in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chalfant, JS1
Skaggs, AW1
Loehfelm, TW1
Fananapazir, G1
Corwin, MT1
Kim, JY1
Kim, SH1
Eun, HW1
Lee, MW1
Lee, JY1
Han, JK1
Choi, BI1

Other Studies

2 other studies available for iohexol and Biliary Tract Cancer

ArticleYear
Incidentally detected biliary ductal dilatation on contrast-enhanced CT: what is the incidence of occult obstructing malignancy?
    Abdominal radiology (New York), 2019, Volume: 44, Issue:12

    Topics: Biliary Tract Neoplasms; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Contrast Medi

2019
Differentiation between biliary cystic neoplasms and simple cysts of the liver: accuracy of CT.
    AJR. American journal of roentgenology, 2010, Volume: 195, Issue:5

    Topics: Adult; Aged; Biliary Tract Neoplasms; Chi-Square Distribution; Contrast Media; Cystadenocarcinoma; C

2010